Literature DB >> 20709949

Neisseria lactamica selectively induces mitogenic proliferation of the naive B cell pool via cell surface Ig.

Andrew T Vaughan1, Louise S Brackenbury, Paola Massari, Victoria Davenport, Andrew Gorringe, Robert S Heyderman, Neil A Williams.   

Abstract

Neisseria lactamica is a commensal bacteria that colonizes the human upper respiratory tract mucosa during early childhood. In contrast to the closely related opportunistic pathogen Neisseria meningitidis, there is an absence of adaptive cell-mediated immunity to N. lactamica during the peak age of carriage. Instead, outer membrane vesicles derived from N. lactamica mediate a B cell-dependent proliferative response in mucosal mononuclear cells that is associated with the production of polyclonal IgM. We demonstrate in this study that this is a mitogenic human B cell response that occurs independently of T cell help and any other accessory cell population. The ability to drive B cell proliferation is a highly conserved property and is present in N. lactamica strains derived from diverse clonal complexes. CFSE staining of purified human tonsillar B cells demonstrated that naive IgD(+) and CD27(-) B cells are selectively induced to proliferate by outer membrane vesicles, including the innate CD5(+) subset. Neither purified lipooligosaccharide nor PorB from N. lactamica is likely to be responsible for this activity. Prior treatment of B cells with pronase to remove cell-surface Ig or treatment with BCR-specific Abs abrogated the proliferative response to N. lactamica outer membrane vesicles, suggesting that this mitogenic response is dependent upon the BCR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20709949     DOI: 10.4049/jimmunol.0902468

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

Review 1.  Immune modulation by bacterial outer membrane vesicles.

Authors:  Maria Kaparakis-Liaskos; Richard L Ferrero
Journal:  Nat Rev Immunol       Date:  2015-05-15       Impact factor: 53.106

2.  Lack of lipid A pyrophosphorylation and functional lptA reduces inflammation by Neisseria commensals.

Authors:  Constance M John; Mingfeng Liu; Nancy J Phillips; Zhijie Yang; Courtney R Funk; Lindsey I Zimmerman; J McLeod Griffiss; Daniel C Stein; Gary A Jarvis
Journal:  Infect Immun       Date:  2012-09-04       Impact factor: 3.441

3.  Molecular mapping to species level of the tonsillar crypt microbiota associated with health and recurrent tonsillitis.

Authors:  Anders Jensen; Helena Fagö-Olsen; Christian Hjort Sørensen; Mogens Kilian
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

4.  Structural and Immunological Characterization of Novel Recombinant MOMP-Based Chlamydial Antigens.

Authors:  Guillermo Madico; Olga Gursky; Jeff Fairman; Paola Massari
Journal:  Vaccines (Basel)       Date:  2017-12-25

5.  Innate and adaptive nasal mucosal immune responses following experimental human pneumococcal colonization.

Authors:  Simon P Jochems; Karin de Ruiter; Carla Solórzano; Astrid Voskamp; Elena Mitsi; Elissavet Nikolaou; Beatriz F Carniel; Sherin Pojar; Esther L German; Jesús Reiné; Alessandra Soares-Schanoski; Helen Hill; Rachel Robinson; Angela D Hyder-Wright; Caroline M Weight; Pascal F Durrenberger; Robert S Heyderman; Stephen B Gordon; Hermelijn H Smits; Britta C Urban; Jamie Rylance; Andrea M Collins; Mark D Wilkie; Lepa Lazarova; Samuel C Leong; Maria Yazdanbakhsh; Daniela M Ferreira
Journal:  J Clin Invest       Date:  2019-07-30       Impact factor: 19.456

Review 6.  Bacterial outer membrane vesicles as a candidate tumor vaccine platform.

Authors:  Shuming Wang; Jiayi Guo; Yang Bai; Cai Sun; Yanhao Wu; Zhe Liu; Xiaofei Liu; Yanfeng Wang; Zhigang Wang; Yongmin Zhang; Huifang Hao
Journal:  Front Immunol       Date:  2022-09-09       Impact factor: 8.786

7.  Antibody and T cell responses to Fusobacterium nucleatum and Treponema denticola in health and chronic periodontitis.

Authors:  Jieun Shin; Sang-A Kho; Yun S Choi; Yong C Kim; In-Chul Rhyu; Youngnim Choi
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.